The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.
Portions of this work were funded by Subcontract No. ZCO-30017-01 with the National Renewable Energy Laboratory under Prime Contract No. DE-AC36-99GO10337 with the U.S. Department of Energy. Accordingly, the United States Government may have certain rights in this invention.
This application is a continuation of U.S. application Ser. No. 11/329,498 filed Jan. 10, 2006, now U.S. Pat. No. 7,449,319 which is a division of U.S. application Ser. No. 10/028,244 filed on Dec. 18, 2001, now U.S. Pat. No. 7,045,331, the teachings of which are incorporated by reference herein in their entirety.